18 December, 2024Noema Pharma appoints Volker Knappertz, M.D., as Executive Vice President of Research & Development
12 December, 2024Tenpoint Therapeutics Ltd. and Visus Therapeutics, Inc. join forces, building the next era of best-and first-in-class ophthalmic medicines
11 December, 2024Noema Pharma extends Series B financing round, closing at CHF130 Million ($147 Million)
11 December, 2024ProQR Therapeutics announces $8.1 million in new funding from Rett Syndrome Research Trust to expand RNA editing collaboration